PALI
PALI
NASDAQ · Biotechnology

Palisade Bio Inc

$1.03
-0.09 (-8.04%)
Analyst Consensus
Strong Buy
16
Analysts
High
Coverage
Buy 15 94%
Hold 1 6%
Sell 0 0%
Price Target
Analyst Price Target +327.2% upside
Low Target $2.36
Average Target $4.40
High Target $4.89
Current Price $1.03
Current
$1.03
Target
$4.40
$2.36 $4.40 avg $4.89
Scenario Analysis
Bear Case
$2.36
129.1%
Low target
Base Case
$4.40
+327.2%
Avg target
Bull Case
$4.89
+374.8%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$2.86
-63.9% from high
52-Week Low
$1.08
+-4.6% from low
Target vs 52W High
$4.40
+54.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.2%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +114.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -17.6%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
MRNA
Moderna Inc
Hold 31 32% $149.45 -30.6%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -50.5%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -31.6%